Global Blood Therapeutics Inc (NASDAQ:GBT)
| 35.43 Delayed Data As of May 13 |  -1.14 / -3.11%Today’s Change | 34.65 Today|||52-Week Range 76.47 | -18.19% Year-to-Date |
Latest GBT News | Press Releases
| Elkhorn Partners Limited Partnership Buys International Flavors & Fragrances Inc, Amazon. ... May 11 / GuruFocus News - Paid Partner Content | Global Blood Therapeutics (GBT) Q1 2021 Earnings Call Transcript May 06 / MotleyFool.com - Paid Partner Content |
| Why Global Blood Therapeutics Stock Is Sinking Today May 06 / MotleyFool.com - Paid Partner Content | Global Blood Therapeutics (GBT) Reports Q1 Loss, Lags Revenue Estimates May 05 / Zacks.com - Paid Partner Content |
| Global Blood's (GBT) Q1 Earnings Miss, Revenues Rise Y/Y May 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 36.60 |
| Today’s open | 36.74 |
| Day’s range | 34.65 - 36.96 |
| Volume | 1,192,629 |
| Average volume (3 months) | 963,140 |
| Market cap | $2.4B |
Data as of 3:59pm ET, 05/13/2021
Growth & Valuation
| Earnings growth (last year) | +11.76% |
| Earnings growth (this year) | -11.58% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +5,773.01% |
| P/E ratio | NM |
| Price/Sales | 21.46 |
| Price/Book | 5.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBHPrestige Consumer He... | -0.02 | -0.04% |
| CORTCorcept Therapeutics... | +0.31 | +1.50% |
| VCELVericel Corp | +0.66 | +1.40% |
| OPKOPKO Health Inc | +0.08 | +2.40% |
Data as of 4:00pm ET, 05/13/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$1.16 |
| Annual revenue (last year) | $123.8M |
| Annual profit (last year) | -$247.6M |
| Net profit margin | -199.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
